Raja, S. N. et al. The revised Worldwide Affiliation for the Research of Ache definition of ache: ideas, challenges, and compromises. Ache 161, 1976–1982 (2020).
Scher, C., Meador, L., Van Cleave, J. H. & Reid, M. C. Transferring past ache because the fifth very important signal and affected person satisfaction scores to enhance ache care within the twenty first century. Ache Manag. Nurs. 19, 125–129 (2018).
Yong, R. J., Mullins, P. M. & Bhattacharyya, N. Prevalence of continual ache amongst adults in the USA. Ache 163, e328–e332 (2022).
Tompkins, D. A., Hobelmann, J. G. & Compton, P. Offering continual ache administration within the ‘fifth very important signal’ period: historic and remedy views on a modern-day medical dilemma. Drug Alcohol Rely. 173, S11–S21 (2017).
Humphreys, Ok. et al. Responding to the opioid disaster in North America and past: suggestions of the Stanford–Lancet Fee. Lancet 399, 555–604 (2022).
Friedman, J. R. & Hansen, H. Analysis of will increase in drug overdose mortality charges within the US by race and ethnicity earlier than and throughout the COVID-19 pandemic. JAMA Psychiatry 79, 379–381 (2022).
Ballantyne, J. C. & Shin, N. S. Efficacy of opioids for continual ache: a assessment of the proof. Clin. J. Ache 24, 469–478 (2008).
Cheatle, M. D. & Savage, S. R. Knowledgeable consent in opioid remedy: a possible obligation and alternative. J. Ache Symptom Handle. 44, 105–116 (2012).
Els, C. et al. Opposed occasions related to medium- and long-term use of opioids for continual non-cancer ache: an summary of Cochrane Opinions. Cochrane Database Syst. Rev. 10, CD012509 (2017).
McDonagh, M. et al. Nonopioid Pharmacologic Remedies for Persistent Ache, Report No. 20-EHC010 (Company for Healthcare Analysis and High quality (US), 2020).
Pushpakom, S. et al. Drug repurposing: progress, challenges and suggestions. Nat. Rev. Drug Discov. 18, 41–58 (2019).
Nielsen, C., Knudsen, G. & Steingrímsdóttir, Ó. Twin research of ache. Clin. Genet. 82, 331–340 (2012).
Abboud, C. et al. Animal fashions of ache: range and advantages. J. Neurosci. Strategies 348, 108997 (2021).
Meng, W. et al. Genome-wide affiliation examine of knee ache identifies associations with GDF5 and COL27A1 in UK Biobank. Commun. Biol. 2, 321 (2019).
Meng, W. et al. A genome-wide affiliation examine finds genetic variants related to neck or shoulder ache in UK Biobank. Hum. Mol. Genet. 29, 1396–1404 (2020).
Suri, P. et al. Genome-wide meta-analysis of 158,000 people of European ancestry identifies three loci related to continual again ache. PLoS Genet. 14, e1007601 (2018).
Freidin, M. B. et al. Perception into the genetic structure of again ache and its danger elements from a examine of 509,000 people. Ache 160, 1361–1373 (2019).
Johnston, Ok. J. et al. Genome-wide affiliation examine of multisite continual ache in UK Biobank. PLoS Genet. 15, e1008164 (2019).
Johnston, Ok. J. et al. Intercourse-stratified genome-wide affiliation examine of multisite continual ache in UK Biobank. PLoS Genet. 17, e1009428 (2021).
Mocci, E. et al. Genome-wide affiliation joint evaluation reveals 99 danger loci for ache susceptibility and pleiotropic relationships with psychiatric, metabolic, and immunological traits. PLoS Genet. 19, e1010977 (2023).
Rahman, M. S. et al. Genome-wide affiliation examine identifies RNF123 locus as related to continual widespread musculoskeletal ache. Ann. Rheum. Dis. 80, 1227–1235 (2021).
Meng, W. et al. A genome-wide affiliation examine finds genetic associations with broadly-defined headache in UK Biobank (N=223,773). EBioMedicine 28, 180–186 (2018).
Boer, C. G. et al. Deciphering osteoarthritis genetics throughout 826,690 people from 9 populations. Cell 184, 4784–4818 (2021).
Zorina-Lichtenwalter, Ok., Parisien, M. & Diatchenko, L. Genetic research of human neuropathic ache circumstances: a assessment. Ache 159, 583–594 (2018).
Meng, W. et al. Genetic correlations between ache phenotypes and despair and neuroticism. Eur. J. Hum. Genet. 28, 358–366 (2020).
Zorina-Lichtenwalter, Ok. et al. Genetic danger shared throughout 24 continual ache circumstances: identification and characterization with genomic structural equation modeling. Ache 164, 2239–2252 (2023).
Troiani, V. et al. Genetics and prescription opioid use (GaPO): examine design for consenting a cohort from an present biobank to determine medical and genetic elements influencing prescription opioid use and abuse. BMC Med. Genomics 14, 253 (2021).
Gaziano, J. M. et al. Million Veteran Program: a mega-biobank to check genetic influences on well being and illness. J. Clin. Epidemiol. 70, 214–223 (2016).
Luther, S. L. et al. Measuring ache care high quality within the Veterans Well being Administration main care setting. Ache 163, e715–e724 (2022).
Farrar, J. T. A consideration of variations in ache scales utilized in medical trials. Ache 163, e1164–e1165 (2022).
Euasobhon, P. et al. Reliability and responsivity of ache depth scales in people with continual ache. Ache 163, e1184–e1191 (2022).
Meloto, C. B. et al. Human ache genetics database: a useful resource devoted to human ache genetics analysis. Ache 159, 749–763 (2018).
Sollis, E. et al. The NHGRI-EBI GWAS catalog: knowledgebase and deposition useful resource. Nucleic Acids Res. 51, D977–D985 (2023).
Yang, C. et al. Genomic atlas of the proteome from mind, CSF and plasma prioritizes proteins implicated in neurological issues. Nat. Neurosci. 24, 1302–1312 (2021).
Uffelmann, E. et al. Genome-wide affiliation research. Nat. Rev. Strategies Primers 1, 59 (2021).
Tsepilov, Y. A. et al. Evaluation of genetically impartial phenotypes identifies shared genetic elements related to continual musculoskeletal ache circumstances. Commun. Biol. 3, 329 (2020).
Finan, C. et al. The druggable genome and help for goal identification and validation in drug improvement. Sci. Transl. Med. 9, eaag1166 (2017).
Valdes, A. M. et al. Affiliation of β-blocker use with much less prevalent joint ache and decrease opioid requirement in individuals with osteoarthritis. Arthritis Care Res. (Hoboken) 69, 1076–1081 (2017).
Nakafero, G. et al. β-blocker prescription is related to decrease cumulative danger of knee osteoarthritis and knee ache consultations in main care: a propensity score-matched cohort examine. Rheumatology (Oxford) 60, 5686–5696 (2021).
Jackson, J. L. et al. A comparative effectiveness meta-analysis of medication for the prophylaxis of migraine headache. PLoS ONE 10, e0130733 (2015).
Diatchenko, L., Parisien, M., Jahangiri Esfahani, S. & Mogil, J. S. Omics approaches to find pathophysiological pathways contributing to human ache. Ache 163, S69–S78 (2022).
Mayr, A. et al. Sufferers with continual ache exhibit individually distinctive cortical signatures of ache encoding. Hum. Mind Mapp. 43, 1676–1693 (2022).
Lee, J. J., Lee, S., Lee, D. H. & Woo, C. W. Purposeful mind reconfiguration throughout sustained ache. eLife 11, e74463 (2022).
Baliki, M. N. et al. Persistent ache and the emotional mind: particular mind exercise related to spontaneous fluctuations of depth of continual again ache. J. Neurosci. 26, 12165–12173 (2006).
Bortsov, A. V. et al. Mind-specific genes contribute to continual however to not acute again ache. Ache Rep. 7, e1018 (2022).
Khoury, S. et al. Genome-wide evaluation identifies impaired axonogenesis in continual overlapping ache circumstances. Mind 145, 1111–1123 (2022).
Enna, S. J. & McCarson, Ok. E. The position of GABA within the mediation and notion of ache. Adv. Pharmacol. 54, 1–27 (2006).
Goudet, C. et al. Metabotropic receptors for glutamate and GABA in ache. Mind Res. Rev. 60, 43–56 (2009).
Dong, W. et al. Exome sequencing implicates impaired GABA signaling and neuronal ion transport in trigeminal neuralgia. iScience 23, 101552 (2020).
Xie, L. et al. Divergent modulation of ache and nervousness by GABAergic neurons within the ventrolateral periaqueductal grey and dorsal raphe. Neuropsychopharmacology 48, 1509–1519 (2023).
Bridge, H. et al. Altered neurochemical coupling within the occipital cortex in migraine with visible aura. Cephalalgia 35, 1025–1030 (2015).
Foerster, B. R. et al. Lowered insular γ-aminobutyric acid in fibromyalgia. Arthritis Rheum. 64, 579–583 (2012).
Wu, X. et al. Elevated GABA stage within the precuneus and its affiliation with ache depth in sufferers with postherpetic neuralgia: an preliminary proton magnetic resonance spectroscopy examine. Eur. J. Radiol. 157, 110568 (2022).
Kang, Y. et al. Efficacy and security of a number of dosages of fostamatinib in grownup sufferers with rheumatoid arthritis: a scientific assessment and meta-analysis. Entrance. Pharmacol. 10, 897 (2019).
Flodin, P. et al. Intrinsic mind connectivity in continual ache: a resting-state fMRI examine in sufferers with rheumatoid arthritis. Entrance. Hum. Neurosci. 10, 107 (2016).
Yang, J., Corridor, J. E., Jose, P. A., Chen, Ok. & Zeng, C. Complete insights in GRK4 and hypertension: from mechanisms to potential therapeutics. Pharmacol. Ther. 239, 108194 (2022).
Olsen, R. B. et al. Hypertension prevalence and diminished blood pressure-related hypoalgesia in people reporting continual ache in a basic inhabitants: the Tromsø Research. Ache 154, 257–262 (2013).
Li, C. Y., Lin, W. C., Lu, C. Y., Chung, Y. S. & Cheng, Y. C. Prevalence of ache in community-dwelling older adults with hypertension in the USA. Sci. Rep. 12, 8387 (2022).
Geisheker, M. R. et al. Hotspots of missense mutation determine neurodevelopmental dysfunction genes and purposeful domains. Nat. Neurosci. 20, 1043–1051 (2017).
Ismail, V. et al. Identification and purposeful analysis of GRIA1 missense and truncation variants in people with ID: an rising neurodevelopmental syndrome. Am. J. Hum. Genet. 109, 1217–1241 (2022).
Aranke, M. et al. Topical sevoflurane: a novel remedy for continual ache brought on by venous stasis ulcers. Anesth. Ache Med. 11, e112832 (2021).
Finnerup, N. B. et al. Pharmacotherapy for neuropathic ache in adults: a scientific assessment and meta-analysis. Lancet Neurol. 14, 162–173 (2015).
Khan, J. S., Hah, J. M. & Mackey, S. C. Results of smoking on sufferers with continual ache: a propensity-weighted evaluation on the collaborative well being outcomes data registry. Ache 160, 2374–2379 (2019).
Nicholas, M. et al. The IASP classification of continual ache for ICD-11: continual main ache. Ache 160, 28–37 (2019).
Goulet, J. L. et al. Settlement between digital medical record-based and self-administered ache numeric score scale: medical and analysis implications. Med. Care 51, 245–250 (2013).
Company Medical Listing Group. Ache Administration. Division of Veterans Affairs Veterans Well being Administration Directive 2009-053 (AMDG, 2009); https://amdg.wa.gov/Files/OpioidConference/12dHuntVAPAINCARETRANSFORMATION.pdf
Hunter-Zinck, H. et al. Genotyping array design and information high quality management within the Million Veteran Program. Am. J. Hum. Genet. 106, 535–548 (2020).
Delaneau, O., Zagury, J. F., Robinson, M. R., Marchini, J. L. & Dermitzakis, E. T. Correct, scalable and integrative haplotype estimation. Nat. Commun. 10, 5436 (2019).
Das, S. et al. Subsequent-generation genotype imputation service and strategies. Nat. Genet. 48, 1284–1287 (2016).
Auton, A. et al. A worldwide reference for human genetic variation. Nature 526, 68–74 (2015).
Fang, H. et al. Harmonizing genetic ancestry and self-identified race/ethnicity in genome-wide affiliation research. Am. J. Hum. Genet. 105, 763–772 (2019).
Chang, C. C. et al. Second-generation PLINK: rising to the problem of bigger and richer datasets. GigaScience 4, 7 (2015).
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: quick and environment friendly meta-analysis of genomewide affiliation scans. Bioinformatics 26, 2190–2191 (2010).
Watanabe, Ok., Taskesen, E., van Bochoven, A. & Posthuma, D. Purposeful mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a device for genome-wide advanced trait evaluation. Am. J. Hum. Genet. 88, 76–82 (2011).
Benner, C. et al. FINEMAP: environment friendly variable choice utilizing abstract information from genome-wide affiliation research. Bioinformatics 32, 1493–1501 (2016).
Benner, C. et al. Prospects of fine-mapping trait-associated genomic areas through the use of abstract statistics from genome-wide affiliation research. Am. J. Hum. Genet. 101, 539–551 (2017).
Bulik-Sullivan, B. Ok. et al. LD rating regression distinguishes confounding from polygenicity in genome-wide affiliation research. Nat. Genet. 47, 291–295 (2015).
Altshuler, D. M. et al. Integrating frequent and uncommon genetic variation in various human populations. Nature 467, 52–58 (2010).
Luo, Y. et al. Estimating heritability and its enrichment in tissue-specific gene units in admixed populations. Hum. Mol. Genet. 30, 1521–1534 (2021).
Finucane, H. Ok. et al. Partitioning heritability by purposeful annotation utilizing genome-wide affiliation abstract statistics. Nat. Genet. 47, 1228–1235 (2015).
Finucane, H. Ok. et al. Heritability enrichment of particularly expressed genes identifies disease-relevant tissues and cell sorts. Nat. Genet. 50, 621–629 (2018).
The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory results throughout human tissues. Science 369, 1318–1330 (2020).
Bernstein, B. E. et al. The NIH roadmap epigenomics mapping consortium. Nat. Biotechnol. 28, 1045–1048 (2010).
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set evaluation of GWAS information. PLoS Comput. Biol. 11, e1004219 (2015).
Sey, N. Y. et al. A computational device (H-MAGMA) for improved prediction of brain-disorder danger genes by incorporating mind chromatin interplay profiles. Nat. Neurosci. 23, 583–593 (2020).
Rajarajan, P. et al. Neuron-specific signatures within the chromosomal connectome related to schizophrenia danger. Science 362, eaat4311 (2018).
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set assortment. Cell Syst. 1, 417–425 (2015).
Watanabe, Ok., Umićević Mirkov, M., de Leeuw, C. A., van den Heuvel, M. P. & Posthuma, D. Genetic mapping of cell sort specificity for advanced traits. Nat. Commun. 10, 3222 (2019).
Fromer, M. et al. Gene expression elucidates purposeful affect of polygenic danger for schizophrenia. Nat. Neurosci. 19, 1442–1453 (2016).
Wingo, T. S. et al. Shared mechanisms throughout the key psychiatric and neurodegenerative illnesses. Nat. Commun. 13, 4314 (2022).
Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide affiliation research. Nat. Genet. 48, 245–252 (2016).
Giambartolomei, C. et al. Bayesian check for colocalisation between pairs of genetic affiliation research utilizing abstract statistics. PLoS Genet. 10, e1004383 (2014).
Zhu, Z. et al. Integration of abstract information from GWAS and eQTL research predicts advanced trait gene targets. Nat. Genet. 48, 481–487 (2016).
Qi, T. et al. Genetic management of RNA splicing and its distinct position in advanced trait variation. Nat. Genet. 54, 1355–1363 (2022).
Ray, P. et al. Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq-based useful resource for ache and sensory neuroscience analysis. Ache 159, 1325–1345 (2018).
Gaulton, A. et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100–D1107 (2012).
Cotto, Ok. C. et al. DGIdb 3.0: a redesign and growth of the drug–gene interplay database. Nucleic Acids Res. 46, D1068–D1073 (2018).
Cuéllar-Partida, G. et al. Advanced-Traits Genetics Digital Lab: a community-driven internet platform for post-GWAS analyses. Preprint at bioRxiv https://doi.org/10.1101/518027 (2019).
Brown, B. C., Ye, C. J., Value, A. L. & Zaitlen, N. Transethnic genetic-correlation estimates from abstract statistics. Am. J. Hum. Genet. 99, 76–88 (2016).
Kember, R. L. et al. Phenome-wide affiliation evaluation of substance use issues in a deeply phenotyped pattern. Biol. Psychiatry 93, 536–545 (2023).
Pierucci-Lagha, A. et al. Diagnostic reliability of the Semi-structured Evaluation for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Rely. 80, 303–312 (2005).
Pierucci-Lagha, A. et al. Reliability of DSM-IV diagnostic standards utilizing the Semi-structured Evaluation for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Rely. 91, 85–90 (2007).
Fuchsberger, C., Abecasis, G. R. & Hinds, D. A. minimac2: sooner genotype imputation. Bioinformatics 31, 782–784 (2015).
Verma, A. et al. The Penn Drugs BioBank: in the direction of a genomics-enabled studying healthcare system to speed up precision medication in a various inhabitants. J. Pers. Med. 12, 1974 (2022).
Ge, T., Chen, C. Y., Ni, Y., Feng, Y. C. & Smoller, J. W. Polygenic prediction through Bayesian regression and steady shrinkage priors. Nat. Commun. 10, 1776 (2019).
Denny, J. C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to find gene–illness associations. Bioinformatics 26, 1205–1210 (2010).
Hemani, G. et al. The MR-base platform helps systematic causal inference throughout the human phenome. eLife 7, e34408 (2018).
Hayes, B. L. et al. Establishing causal relationships between sleep and adiposity traits utilizing Mendelian randomization. Weight problems 31, 861–870 (2023).
Xiao, G. et al. Estimating the causal impact of frailty index on vestibular issues: a two-sample Mendelian randomization. Entrance. Neurosci. 16, 990682 (2022).
Palmer, T. M. et al. Utilizing a number of genetic variants as instrumental variables for modifiable danger elements. Stat. Strategies Med. Res. 21, 223–242 (2012).
Hemani, G., Tilling, Ok. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits utilizing GWAS abstract information. PLoS Genet. 13, e1007081 (2017).
Sheehan, N. A., Didelez, V., Burton, P. R. & Tobin, M. D. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 5, e177 (2008).
Greco, M. F., Minelli, C., Sheehan, N. A. & Thompson, J. R. Detecting pleiotropy in Mendelian randomisation research with abstract information and a steady final result. Stat. Med. 34, 2926–2940 (2015).